PPARG and glioma: PPARγ agonists have therefore been proposed as novel anti-neoplastic agents for the treatment of glioma, although currently these drugs have not been evaluated in serum-free glioma cell cultures or direct-to-xenograft animal models (Ellis and Kurian, 2014).